Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs Heros Health

Alan Meds
Graded #98

Higher grade

vs+4.799999999999997
Heros Health
Graded #190

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 66.3/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +12
72
60
Dose & formulationAlan Meds +11
75
64
Clinical oversightHeros Health +5
82
87
Labs & monitoringHeros Health +1
53
54
FulfillmentAlan Meds +2
78
76
Contract termsAlan Meds +6
55
49
Alan Meds · left barHeros Health · right bar

The numbers

MetricAlan MedsHeros Health
WeighScore71.1/10066.3/100
GradeCC
Scorecard rank#98#190
Semaglutide$158/mo (compounded)$199/mo (compounded)
Tirzepatide$295/mo (compounded)$199/mo (compounded)
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Alan Meds

Graded #98 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
Heros Health

Graded #190 · C

Strengths

  • Compounded semaglutide and tirzepatide on a flat program price, not tiered by dose
  • Transparent pricing: $149 first month, then $199/mo (or $165/mo on the 3-month plan)
  • 90-day money-back guarantee on GLP-1 treatment
  • Dose adjustments at weeks 2, 4, and 8 included at no extra cost
  • Named board-certified physicians (Dr. Amber Patel, Dr. Scott Sanderson, Dr. Scott Nass)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Specific 503A pharmacy partner is not named publicly
  • State coverage is stated inconsistently on the site (claims both 50 and 46 states)
  • No insurance billing — cash-pay only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard